Expanded trial access FOMAT operates 80+ sites across multiple states, enabling closer-to-patient recruitment for Phase I to IV studies. This presents a sales opportunity to offer centralized trial design and site-network optimization services to sponsors seeking diverse patient populations and faster enrollment.

Diverse therapeutic reach With broad therapeutic coverage from allergy to oncology and pediatrics, FOMAT can be positioned as a versatile embedded research partner for multi-indication trials, appealing to sponsors running multi-therapy portfolios or needing cross-specialty coordination.

Patient-centric differentiation Awards and recognition for patient inclusion and centricity, along with a community-based model, highlight value in patient engagement, retention, and diverse enrollment—a strong differentiator for sponsors prioritizing real-world representativeness.

Growth through partnerships Recent collaborations with Golden Valley Health Centers and specialty clinics indicate a strategy of expanding access through partnerships with healthcare networks, suggesting sales targets around network expansion, community outreach, and registry or bridging studies.

Leadership and growth New leadership hires in business development and expanded operations signal a focus on scaling client acquisition, project delivery, and cross-sell opportunities within existing sponsor pipelines, offering a pathway for tailored solution selling and white-glove execution.